Resumen de acción 1302
LifeTech Scientific Corporation, sociedad de cartera de inversiones, desarrolla, fabrica y comercializa en todo el mundo dispositivos médicos de intervención para enfermedades y trastornos cardiovasculares y vasculares periféricos.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de LifeTech Scientific Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.72 |
| 52 Week High | HK$3.02 |
| 52 Week Low | HK$1.56 |
| Beta | 0.73 |
| 1 Month Change | -2.27% |
| 3 Month Change | -3.37% |
| 1 Year Change | -34.10% |
| 3 Year Change | -56.12% |
| 5 Year Change | 7.50% |
| Change since IPO | 588.00% |
Noticias y actualizaciones recientes
LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25
What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28Recent updates
LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?
Nov 03Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
Aug 17Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?
Jul 18Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
May 05Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return
Oct 14There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital
Jul 15Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?
Jun 30A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)
Jun 15Returns At LifeTech Scientific (HKG:1302) Are On The Way Up
Apr 03Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
Mar 15Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?
Jan 22Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital
Dec 19Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today
Dec 06Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued
Oct 12The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence
Sep 13Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?
Aug 28What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?
Aug 13LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
Jun 08Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
May 26Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?
May 11LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%
Feb 21Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?
Jan 26Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13
Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?
Nov 25Rentabilidad de los accionistas
| 1302 | HK Medical Equipment | Mercado HK | |
|---|---|---|---|
| 7D | 4.9% | 8.0% | 4.3% |
| 1Y | -34.1% | -45.9% | -8.5% |
Rentabilidad vs. Industria: 1302 superó al sector Hong Kong Medical Equipment , que obtuvo un rendimiento del -48.4% el año pasado.
Rentabilidad vs. Mercado: 1302 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -10.1% el año pasado.
Volatilidad de los precios
| 1302 volatility | |
|---|---|
| 1302 Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.0% |
| 10% least volatile stocks in HK Market | 3.6% |
Precio estable de las acciones: 1302 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1302 (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1999 | 1,448 | Yuehui Xie | www.lifetechmed.com |
LifeTech Scientific Corporation, un holding de inversiones, desarrolla, fabrica y comercializa dispositivos médicos intervencionistas para enfermedades y trastornos cardiovasculares y vasculares periféricos en todo el mundo. La empresa opera a través de los segmentos de negocio Enfermedades Cardíacas Estructurales, Enfermedades Vasculares Periféricas y Estimulación Cardíaca y Electrofisiología. Sus productos incluyen los sistemas de cierre de la orejuela auricular izquierda LAmbre, así como los oclusores de CIV CeraFlex, Cera, HeartR y Konar-MF; los sistemas de endoprótesis cubierta para aneurisma aórtico torácico y aneurisma aórtico abdominal Ankura; los sistemas de agujas endovasculares Futhrough; sistemas de colocación, como los introductores Fustar steerable y SteerEase; la guía Zoetrack; los filtros de vena cava Aegisy; los sistemas de tapones vasculares Cera; los balones de calibrado AcuMark; el sistema de marcapasos cardíaco implantable HearTone; y los sistemas de asa SeQure, así como marcapasos.
Resumen de fundamentos de LifeTech Scientific Corporation
| Estadísticas fundamentales de 1302 | |
|---|---|
| Capitalización bursátil | HK$7.96b |
| Beneficios(TTM) | HK$284.32m |
| Ingresos (TTM) | HK$1.37b |
28.0x
Ratio precio-beneficio (PE)5.8x
Ratio precio-ventas (PS)¿Está 1302 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 1302 | |
|---|---|
| Ingresos | CN¥1.27b |
| Coste de los ingresos | CN¥271.54m |
| Beneficio bruto | CN¥995.64m |
| Otros gastos | CN¥732.40m |
| Beneficios | CN¥263.24m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.057 |
| Margen bruto | 78.57% |
| Margen de beneficio neto | 20.77% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado 1302 a largo plazo?
Ver rendimiento histórico y comparativa